No fewer than seven public health organisations and medical groups filed a lawsuit on Tuesday (March 27) against the US Food and Drug Administration after they said that e-cigarettes can remain on the US market for years without a regulatory review.
The Food and Drug Administration, the body that regulates e-cigarettes and tobacco products in the United States, has long been planning to treat vaping as if it were smoking, following the deeming regulation which came to prominence in 2016.
However, last August, the FDA delayed the rule and Erika Sward, assistant vice president of the national advocacy of the American Lung Association, argues that in the background of the FDA delay, teen use of cigarettes, cigars and e-cigarettes has risen.
Sward said that filing the lawsuit in a federal court in Greenbelt, Maryland, was “the only remedy they thought they could take”.
The FDA delayed the 2016 rule which dictated that e-cigarette makes had to provide information about their products and undergo federal review by up to six years.
Moreover, the FDA delayed their September 30th deadline for e-cigarette manufacturers to sign up for the new agreement.
With all of this considered, it seems that the FDA’s tone and application to e-cig regulation may have changed ever so slightly since the departure of Barrack Obama and the arrival of Donald Trump.
It remains to be seen what comes of the case, titled American Academy of Pediatrics v. Food and Drug Administration, U.S. District Court, District of Maryland, No. 18-cv-00883.
Other than the American Lung Association, the other parties involved are the American Academy of Pediatrics and its Maryland chapter; American Cancer Society Cancer Action Network; American Heart Association; Campaign for Tobacco-Free Kids; Truth Initiative; and five paediatricians.